Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients


We employed a customized Multiple Myeloma (MM)-specific Mutation Panel (M(3)P) to screen a homogenous cohort of 142 untreated MM patients for relevant mutations in a selection of disease-specific genes. M(3)Pv2.0 includes 77 genes selected for being either actionable targets, potentially related to drug-response or part of known key pathways in MM biology… (More)
DOI: 10.1038/bcj.2016.1


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics